Hepatitis B virus (HBV) infection acquired at birth or during early infancy can lead to lifelong health complications, including chronic liver disease. Despite longstanding recommendations for prenatal screening, an estimated 12% to 16% of pregnant individuals in the US are not screened for hepatitis B. This gap leaves a portion of newborns at risk for undetected exposure.
Modeling the synergy of maternal screening and newborn HBV vaccination
- Post author:admin
- Post published:April 28, 2026
- Post category:uncategorized